Scientific topics
Keywords
ITMO
Philippe Ratajczak PhD, Senior Research Associate, Inserm
Course and current status
Philippe Ratajczak was born in 1974. He graduated in Biology and Pharmacology of Hemostasis and Vascular Biology in 1998 and got his PhD, supervised by Dr Jane-Lyse Samuel in Paris (January 2004) from the Paris 7 Denis Diderot University. He worked on heart failure, studying the molecular control of nitric oxide sythase activity by membrane microdomains. From 2004 to 2005, he was a post-doctoral research assistant at Lille Institute Pasteur, studying degenerative vascular disease (i.e. aortic abdominal aneurysm and stroke) using proteomic and genomic approaches with Dr Florence Pinet. Since 2005, he joined the Laboratory UMR-S728 at Saint Louis Hospital to work on endothelial lesions in graft versus host disease, complication of hematopoietic stem cell biotherapy, and development of specific imaging and therapeutics on endothelial and tumoral cells. Since 2011, he is senior research associate in the same laboratory (CCS7 Inserm, drugs, chemistry biology interface, bio-engineering, biotherapies, pharmacology and toxicology). He has obtained for his research programs several grants from INCa, Agence de la Biomédecine, Région Ile de France.
Scientific summary
Philippe Ratajczak was born in 1974. He graduated in Biology and Pharmacology of Hemostasis and Vascular Biology in 1998 and got his PhD, supervised by Dr Jane-Lyse Samuel in Paris (January 2004) from the Paris 7 Denis Diderot University. He worked on heart failure, studying the molecular control of nitric oxide sythase activity by membrane microdomains. From 2004 to 2005, he was a post-doctoral research assistant at Lille Institute Pasteur, studying degenerative vascular disease (i.e. aortic abdominal aneurysm and stroke) using proteomic and genomic approaches with Dr Florence Pinet. Since 2005, he joined the Laboratory UMR-S728 at Saint Louis Hospital to work on endothelial lesions in graft versus host disease, complication of hematopoietic stem cell biotherapy, and development of specific imaging and therapeutics on endothelial and tumoral cells. Since 2011, he is senior research associate in the same laboratory (CCS7 Inserm, drugs, chemistry biology interface, bio-engineering, biotherapies, pharmacology and toxicology). He has obtained for his research programs several grants from INCa, Agence de la Biomédecine, Région Ile de France.
